gimli
LAURUSLABS stock analysis context
LAURUS LABS Stock Context for AI Screening
LAURUS LABS LIMITED is a large-cap stock in Healthcare. This page summarizes key screening signals for LAURUS LABS, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about LAURUSLABSPrice
₹1,343.50
1M return
+22.57%
3M return
+31.84%
Market cap
₹72,529.73 cr
PE
97.93
ROE
+16.99%
RSI
77.11
Turnover
₹228.21 cr
Why it can matter in screens
- Momentum: LAURUSLABS is above 50DMA, above 200DMA; RSI is 77.11.
- Returns: 1M +22.57%, 3M +31.84%, 6M +37.34%.
- Liquidity: latest turnover is ₹228.21 cr.
- Valuation: PE 97.93, PB n/a, ROE +16.99%, ROCE +16.91%.
- Growth: 3Y sales CAGR +4.06%, 3Y profit CAGR -24.34%.
Try these prompts
- Analyze LAURUS LABS with valuation, momentum and industry peers
- Compare LAURUSLABS with other Healthcare stocks
- Show large-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View large-cap stocks
- Find stocks above 50DMA
- Compare LAURUSLABS with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.